open access

Vol 23, No 2 (2016)
INTERVENTION/VALVULAR HEART DISEASE - Original articles
Submitted: 2015-11-28
Accepted: 2016-01-14
Published online: 2016-01-26
Get Citation

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor® porcine prosthetic valves

Raul A. Borracci, Miguel Rubio, Maria L. Sestito, Carlos A. Ingino, Carlos Barrero, Carlos A. Rapallo
DOI: 10.5603/CJ.a2016.0011
·
Pubmed: 26876065
·
Cardiol J 2016;23(2):178-183.

open access

Vol 23, No 2 (2016)
INTERVENTION/VALVULAR HEART DISEASE - Original articles
Submitted: 2015-11-28
Accepted: 2016-01-14
Published online: 2016-01-26

Abstract

Background: The aim was to assess the incidence of prosthesis-patient mismatch (PPM) after mitral valve replacement (MVR) in patients receiving Biocor® porcine or mechanical valves, and to evaluate the effect of PPM on long-term survival.

Methods: All patients undergoing MVR between 2009 and 2013 received either mechanical or bioprosthetic valves (Biocor® porcine). PPM was defined as severe when the indexed effective ori­fice area was < 0.9 cm2/m2, moderate between 0.9 cm2/m2 and 1.2 cm2/m2 or absent > 1.2 cm2/m2. The primary endpoint was all-cause long-term mortality.

Results: Among a total of 136 MVR, PPM was severe in 27%, moderate in 44% and absent in 29% of patients. Implanted valves were 57% mechanical and 43% bioprosthetic. Only 3% of patients with mechanical valves had severe PPM vs. 59% with bioprostheses (p < 0.0001). Sixty-month survival with severe mismatch was 0.559 (SE 0.149) and with no mismatch 0.895 (SE 0.058) (p = 0.043). Survival of patients suffering from severe mismatch, or moderate mismatch with pulmonary hypertension (PH) was 0.749 (SE 0.101); while for patients with no mismatch or with moderate mismatch without PH, survival was 0.951 (SE 0.028) (p = 0.016).

Conclusions: About one-fourth of patients had severe PPM and almost all of them had received a bioprosthesis. Sixty-month survival was significantly lower in patients with severe mismatch, or moderate mismatch with PH. Specifically, when a bioprothesis is chosen and while further evidence on the impact of PPM on clinical outcomes appears, surgeons are recommended to follow a preoperative strategy to implant a mitral prosthesis of adequate size in order to prevent PPM

Abstract

Background: The aim was to assess the incidence of prosthesis-patient mismatch (PPM) after mitral valve replacement (MVR) in patients receiving Biocor® porcine or mechanical valves, and to evaluate the effect of PPM on long-term survival.

Methods: All patients undergoing MVR between 2009 and 2013 received either mechanical or bioprosthetic valves (Biocor® porcine). PPM was defined as severe when the indexed effective ori­fice area was < 0.9 cm2/m2, moderate between 0.9 cm2/m2 and 1.2 cm2/m2 or absent > 1.2 cm2/m2. The primary endpoint was all-cause long-term mortality.

Results: Among a total of 136 MVR, PPM was severe in 27%, moderate in 44% and absent in 29% of patients. Implanted valves were 57% mechanical and 43% bioprosthetic. Only 3% of patients with mechanical valves had severe PPM vs. 59% with bioprostheses (p < 0.0001). Sixty-month survival with severe mismatch was 0.559 (SE 0.149) and with no mismatch 0.895 (SE 0.058) (p = 0.043). Survival of patients suffering from severe mismatch, or moderate mismatch with pulmonary hypertension (PH) was 0.749 (SE 0.101); while for patients with no mismatch or with moderate mismatch without PH, survival was 0.951 (SE 0.028) (p = 0.016).

Conclusions: About one-fourth of patients had severe PPM and almost all of them had received a bioprosthesis. Sixty-month survival was significantly lower in patients with severe mismatch, or moderate mismatch with PH. Specifically, when a bioprothesis is chosen and while further evidence on the impact of PPM on clinical outcomes appears, surgeons are recommended to follow a preoperative strategy to implant a mitral prosthesis of adequate size in order to prevent PPM

Get Citation

Keywords

prosthesis-patient mismatch, mitral valve replacement, bioprosthetic valves, pulmonary hypertension, long-term survival

About this article
Title

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor® porcine prosthetic valves

Journal

Cardiology Journal

Issue

Vol 23, No 2 (2016)

Pages

178-183

Published online

2016-01-26

Page views

1440

Article views/downloads

1424

DOI

10.5603/CJ.a2016.0011

Pubmed

26876065

Bibliographic record

Cardiol J 2016;23(2):178-183.

Keywords

prosthesis-patient mismatch
mitral valve replacement
bioprosthetic valves
pulmonary hypertension
long-term survival

Authors

Raul A. Borracci
Miguel Rubio
Maria L. Sestito
Carlos A. Ingino
Carlos Barrero
Carlos A. Rapallo

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl